R. Giuliani
Impact in
- Oncology top 5%
- Cancer Risks and Factors
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Treatments and Studies 6
- HER2/EGFR in Cancer Research 5
-
- Health Systems, Economic Evaluations, Quality of Life 4
- Co-authors
- Solange Peters (3 shared papers)Elisabeth G.E. de Vries (4 shared papers)Martine Piccart (5 shared papers)Francesco Pignatti (6 shared papers)Fátima Cardoso (3 shared papers)Malvika Vyas (3 shared papers)Josep Tabernero (3 shared papers)Ravindran Kanesvaran (1 shared paper)
- Journals
- ESMO Open (7 papers)Journal of Clinical Oncology (7 papers)Annals of Oncology (4 papers)The Oncologist (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- ItalyNetherlandsUnited Kingdom
In The Last Decade
R. Giuliani
30 papers receiving 831 citations
Peers
Comparison fields: 5 of 74
- Oncology 439
- Cancer Research 117
- Immunology 124
- Hematology 46
- Hepatology 30
Countries citing papers authored by R. Giuliani
This map shows the geographic impact of R. Giuliani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Giuliani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Giuliani more than expected).
Fields of papers citing papers by R. Giuliani
This network shows the impact of papers produced by R. Giuliani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Giuliani. The network helps show where R. Giuliani may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Giuliani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 144 | |
| 2 | 2009 | 132 | |
| 3 | 2016 | 93 | |
| 4 | 2021 | 66 | |
| 5 | 2023 | 54 | |
| 6 | 2013 | 46 | |
| 7 | 2019 | 42 | |
| 8 | 2021 | 37 | |
| 9 | Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer. | 2003 | 33 |
| 10 | 2009 | 31 | |
| 11 | 2012 | 30 | |
| 12 | 2005 | 18 | |
| 13 | 2000 | 16 | |
| 14 | 2000 | 16 | |
| 15 | 2014 | 15 | |
| 16 | 2021 | 13 | |
| 17 | 2013 | 11 | |
| 18 | 2002 | 11 | |
| 19 | 2022 | 9 | |
| 20 | 2018 | 7 |
About R. Giuliani
R. Giuliani is a scholar working on Oncology, Economics and Econometrics, Cancer Research, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 854 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (6 papers), HER2/EGFR in Cancer Research (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Breast Cancer Treatment Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Biosimilars and Bioanalytical Methods (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (439 citations), Cancer Research (117 citations), Immunology (124 citations), Hematology (46 citations) and Hepatology (30 citations). R. Giuliani has collaborated with scholars based in Italy, Netherlands and United Kingdom. Frequent co-authors include Solange Peters, Elisabeth G.E. de Vries, Martine Piccart, Francesco Pignatti, Fátima Cardoso, Malvika Vyas, Josep Tabernero, Ravindran Kanesvaran, Marina Chiara Garassino and Tomas Salmonson. Their work appears in journals such as ESMO Open, Journal of Clinical Oncology, Annals of Oncology, The Oncologist and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.